Reconstructive transplantation · United Kingdom
Hand and upper-limb transplantation — the honest UK picture.
Hand transplantation is one of the rarest operations in modern medicine — fewer than two hundred worldwide since 1998, and fewer than ten in the UK. This is what it actually involves, who it fits, and what the alternatives look like.
Why patients come to us first
- 01
One UK programme, one honest referral
Hand transplantation in the UK happens in one place — Leeds Teaching Hospitals, NHS-funded through Highly Specialised Services. We help you understand whether referral is even the right conversation.
- 02
Alternatives on the table first
Modern prostheses, targeted muscle reinnervation and osseointegration are working better every year. We say so before a transplant assessment is even considered.
- 03
Independent, and free
We are paid by no clinic and no manufacturer, so the guidance is impartial and costs you nothing.
Pathway and cost
NHS-funded, not private — and rightly so.
Hand transplantation in the UK is commissioned by NHS England Highly Specialised Services and delivered from Leeds. It is not offered privately here. What we can help with, privately, is the honest read of whether the pathway fits at all.
In short
First-year care alone runs £300k–£500k, funded by the NHS. Private hand transplant is not offered in the UK.
| Item | Indicative cost | Typical duration | Setting |
|---|---|---|---|
| NHS hand transplant (via HSS referral) | NHS-funded | 6–15 hr surgery | Years of care |
| First-year care (surgery, ITU, ward, therapy) | ~£300k–£500k (NHS) | First 12 months | Inpatient + outpatient |
| Lifetime immunosuppression + monitoring | NHS-funded | Lifelong | Ongoing |
| Private hand transplant in the UK | Not offered | — | — |
| Consultant hand-surgery opinion (alternatives) | £300–£600 | 45–60 min | Same visit |
| Concierge review of your case (no obligation) | Free for patients | Within 1 day | Written back |
The costs shown reflect the resource commitment the NHS makes when a hand transplant proceeds — surgery, ITU, months of ward care, hand therapy, and lifelong immunosuppression and monitoring. There is no private route in the UK, and the honest reason for that is the sheer complexity and the risk of taking on a patient the multidisciplinary system cannot support.
The problem
The right expectation, before the right conversation.
A hand transplant is not a hand back. It is a decade-long commitment to immunosuppression, hand therapy, cancer screening and living with someone else’s tissue. The failure mode is under-informed decisions, not surgical technique.
-
Not sure it is even possible?
Level of amputation, general health, and psychological readiness decide most cases. We give you an honest read within a working day.
-
Wondering about modern prostheses?
Myoelectric hands, targeted muscle reinnervation and osseointegration have improved sharply. Sometimes they are the right answer.
-
Want to understand the Leeds pathway?
What multidisciplinary work-up looks like, what listing means, and how long you might wait for a matched donor.
The journey
From first enquiry through years of recovery — what happens, in order.
The Leeds team leads clinical care. We stay alongside patients and families to translate, chase and prepare.
Phase 1 · Before the transplant
Work-up over months to years
Phase 2 · Surgery and early recovery
Weeks in Leeds
Phase 3 · Life afterwards
Years, and lifelong care
- 01
Before
You tell us what happened
A confidential conversation. Level of amputation, when it happened, what prostheses you have tried, what you hope for.
- 02
Before
We come back with an honest read
Within a working day: whether hand transplantation is even in the frame, what the realistic alternatives are, and what a Leeds referral pathway looks like.
- 03
Before
Multi-year work-up begins
If the pathway is right, the Leeds team leads a work-up over months to years — plastic surgery, transplant medicine, psychology, hand therapy, ethics, tissue typing and prosthesis trial.
- 04
Surgery
The call comes for a donor
A matched donor hand or hands become available. Admission to Leeds, final counselling, and dual-team surgery lasting 6–15 hours.
- 05
Surgery
ITU and early ward care
Two to four weeks on intensive care, months on the ward. Bony fixation, tendon coaptation, microvascular anastomosis and nerve repair are all watched closely.
- 06
Surgery
Hand therapy starts within weeks
Intensive hand therapy from around week four to six — five to seven days a week initially, alongside triple immunosuppression.
- 07
After
Recovery over years, not months
Nerve regeneration runs at roughly a millimetre a day. Useful pinch and grip develop over twelve to thirty-six months. Immunosuppression is lifelong.
Realistic timeline: months to years from first enquiry to listing. Useful function: 12–36 months after surgery. Immunosuppression: lifelong.
Who it fits
The people the pathway is designed for.
The commonest situations, and the one red flag that usually means transplantation is not on the table right now.
-
Bilateral major upper-limb amputation
Loss of both hands or forearms is the group where hand transplantation is most likely to be considered.
-
Unilateral distal forearm loss
Through-wrist or distal-forearm amputation gives the best chance of useful motor and sensory recovery.
-
Mid-forearm amputation
Harder ground — nerve regeneration has further to travel and the functional ceiling is lower.
-
Prosthesis has been tried and failed
A documented trial of a modern prosthesis is expected before transplantation is entertained.
-
Complex traumatic loss
Blast, crush and high-voltage injuries with intact proximal nerves may still be candidates after full work-up.
-
Congenital limb absence
Very rarely a candidate — the cortical representation and nerve substrate needed for recovery may not be present.
-
Proximal-to-elbow amputation
Very rare — the functional outcome is poor because nerves must regenerate over long distances.
-
Red flag: active malignancy or severe systemic disease
Untreated cancer, HIV/HBV/HCV, or severe cardiac or pulmonary disease usually rules transplantation out for now.
Alternatives and adjuncts
Transplantation is one option — not the only one.
What sits alongside or instead of hand transplantation, and which route fits which situation.
-
Modern myoelectric prosthesis
Multi-articulating hands controlled by residual muscle signals. No immunosuppression, and the technology is moving quickly.
-
Targeted muscle reinnervation (TMR)
Cut nerves are redirected to remaining muscles to give richer prosthesis control and reduce neuroma pain.
-
Osseointegration
A titanium implant anchored into bone carries the prosthesis directly — improved control and skeletal loading, without a socket.
-
Hand transplant — unilateral
A single donor hand transplanted onto one recipient forearm. Rare in the UK — around ten cases performed since 2012.
-
Hand transplant — bilateral
Both hands transplanted. Technically more demanding and the immunological burden is greater, but the functional gain can be transformative.
-
Composite tissue reconstruction
Free flaps, toe-to-hand transfers or partial hand reconstruction — a serious option when transplantation is not appropriate.
-
Pain and neuroma management
Nerve wrapping, RPNI and neuroma surgery to make an existing residuum comfortable and prosthesis-ready.
-
A second opinion, no obligation
An honest read of your case from a consultant hand surgeon and, if the case warrants it, a route to the Leeds team.
The UK programme, and its history
A young speciality, with a short honest history.
Clint Hallam’s hand transplant in Lyon in 1998 was the world’s first; he asked for it to be amputated in 2001 after struggling with immunosuppression. Matthew Scott, in Louisville in 1999, was the first successful case. Mark Cahill, operated on by Professor Simon Kay and colleagues at Leeds in 2012, was the UK’s first. Bilateral transplants are more challenging still.
What we look for in a private opinion
How we choose the surgeons and hand therapists we route patients to.
-
Consultant plastic and hand surgeons with reconstructive microsurgery training, not general practitioners
-
Understanding of the Leeds hand transplant programme and NHS Highly Specialised Services pathway
-
Modern prosthesis, TMR and osseointegration options discussed before any transplant conversation
-
Psychology and hand-therapy support available alongside surgical opinion
Risks and life afterwards
What years afterwards actually look like.
Hand transplantation is not a hand back — it is a decade of medicine, therapy and psychological work in exchange for the chance of useful function. Every candidate deserves this in full before consenting.
-
Rejection is common in the first year
Acute rejection happens in seventy to eighty per cent of hand transplants within the first year — skin is the most immunogenic tissue in the body. Pulse steroids usually settle it.
-
Immunosuppression is for life
Tacrolimus, mycophenolate and prednisolone are taken every day, forever. Missing doses is the commonest reason grafts are lost — Clint Hallam’s 1998 transplant was amputated for exactly this reason.
-
Opportunistic infection
CMV, EBV, PJP, aspergillus and HHV-6 are the ones the team watches for. Prophylactic antivirals and antibiotics are used, and screening never really stops.
-
Post-transplant lymphoproliferative disease
PTLD is EBV-driven and one of the more serious late complications of any organ or composite transplant. It is treatable, but must be caught early.
-
Skin cancer, especially SCC
Long-term immunosuppression sharply raises the risk of squamous cell carcinoma. Annual dermatology review and rigorous sun protection are part of life afterwards.
-
Metabolic side effects
Steroids can cause diabetes, hypertension and weight gain. Tacrolimus is nephrotoxic — kidney function needs lifelong monitoring.
-
Graft loss and cardiovascular risk
Around ten to fifteen per cent of grafts are lost by five years, sometimes requiring amputation. Cardiovascular death is the largest long-term mortality driver — five to ten per cent at ten years.
-
Psychological adjustment is real work
Living with another person’s hands — visible, touched every day, sometimes photographed by the press — asks a lot. Ongoing psychological support is not optional.
-
Motor recovery takes years
Useful pinch and grip develop over twelve to thirty-six months as nerves regenerate at roughly a millimetre a day. Fine dexterity is often incomplete. Realistic expectations matter more than almost anything else.
Reading your transplant clinic letter
Your clinic letter in four parts. Read the last one first.
The Leeds transplant clinic letters keep to a consistent shape — this is how to make sense of one on your kitchen table.
A quiet reminder
Transplant language is precise and can read coldly — we translate it for you.
If you would like us to sit with you and go through a letter before the next clinic, just ask.
- 01 Header
Indication and level of amputation
Why you were considered — bilateral loss, unilateral distal forearm, traumatic mid-forearm — and what the team is aiming to restore.
- 02 Technique
Surgery and immunosuppression protocol
Bony fixation, tendon and nerve coaptation, arterial and venous anastomosis, and the induction and maintenance immunosuppression chosen.
- 03 Findings
Rejection episodes, infections, function
Any acute rejection, opportunistic infection, metabolic side effect, and the current motor and sensory function on validated scoring.
- 04 Impression
Function, monitoring plan, next review
Read this first: how the hand is working now, when you are next seen, and what is being monitored — bloods, biopsy schedule, dermatology.
Commissioned and supporting centres in the UK
Hand transplantation is commissioned by NHS England Highly Specialised Services and delivered at Leeds Teaching Hospitals. Private hand transplantation is not offered in the UK.
Frequently asked
Everything we get asked about hand transplantation.
Quick, honest answers on candidacy, surgery, immunosuppression, recovery and long-term risk.
-
Is a hand transplant available privately in the UK?
No. In the UK, hand transplantation is only offered through the NHS Highly Specialised Services pathway, delivered by the team at Leeds Teaching Hospitals led by Professor Simon Kay, whose team performed the UK’s first hand transplant on Mark Cahill in 2012.
-
How many hand transplants have been done in the UK?
Very few — fewer than ten in the UK to date. Worldwide the number is under two hundred since Clint Hallam’s first hand transplant in Lyon in 1998 and Matthew Scott’s first US case in Louisville in 1999.
-
Who is considered for a hand transplant?
Adults, usually aged 18 to 65, with unilateral or bilateral major upper-limb amputation — ideally through-wrist or distal forearm — who are fit for lifelong immunosuppression, have a documented prosthesis trial, and have passed extensive psychological screening. No active cancer, no HIV/HBV/HCV, no severe cardiac or pulmonary disease.
-
What does the work-up involve?
Months to years of multi-disciplinary assessment: plastic surgery, transplant medicine, immunology, psychology and psychiatry, hand therapy, social work and ethics. Tissue typing, HLA and PRA screening, immunological cross-match, and a documented trial of modern prosthesis all sit within it.
-
What happens during the surgery?
Dual teams work in parallel on the donor and recipient. Bony fixation is done first with plating, then tendon coaptation, microvascular arterial and venous anastomosis, motor and sensory nerve coaptation of the median, ulnar and radial nerves, and finally skin closure. The whole operation takes six to fifteen hours.
-
What does immunosuppression involve?
Induction with basiliximab or thymoglobulin, then lifelong maintenance with tacrolimus, mycophenolate mofetil and prednisolone. Acute rejection is common in the first year — around seventy to eighty per cent — and is usually treated with pulse steroids, sometimes rituximab or photopheresis.
-
How long until the hand works?
Nerves regenerate at about one millimetre a day, so useful function returns over twelve to thirty-six months, not weeks. Around thirty per cent of patients return to work. Motor function usually reaches useful pinch and grip; fine dexterity is often incomplete.
-
What are the main risks?
Acute and chronic rejection, opportunistic infection, post-transplant lymphoproliferative disease, skin cancer (especially squamous cell), steroid-driven diabetes and hypertension, tacrolimus-related kidney damage, graft loss (ten to fifteen per cent at five years) sometimes requiring amputation, and cardiovascular death (five to ten per cent at ten years). Some patients also struggle psychologically and choose to have the transplant removed — Clint Hallam being the best-known example.
Related pages